I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 21% ± 2% | |
| GABAergic neuron | 3 studies | 21% ± 2% | |
| glutamatergic neuron | 3 studies | 30% ± 4% | |
| transit amplifying cell | 3 studies | 35% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 3 studies | 21% ± 2% | |
| GABAergic neuron | 3 studies | 21% ± 2% | |
| glutamatergic neuron | 3 studies | 30% ± 4% | |
| transit amplifying cell | 3 studies | 35% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 889.32 | 180 / 180 | 100% | 38.42 | 430 / 430 |
| esophagus | 100% | 1041.02 | 1444 / 1445 | 100% | 47.86 | 183 / 183 |
| breast | 100% | 1099.63 | 459 / 459 | 100% | 41.62 | 1117 / 1118 |
| lung | 100% | 781.12 | 576 / 578 | 100% | 33.36 | 1155 / 1155 |
| stomach | 100% | 848.37 | 359 / 359 | 100% | 43.57 | 285 / 286 |
| intestine | 100% | 1088.09 | 966 / 966 | 99% | 43.19 | 524 / 527 |
| bladder | 100% | 969.52 | 21 / 21 | 99% | 38.38 | 501 / 504 |
| uterus | 100% | 1044.41 | 170 / 170 | 99% | 44.31 | 454 / 459 |
| prostate | 100% | 786.77 | 245 / 245 | 98% | 18.17 | 492 / 502 |
| brain | 99% | 567.06 | 2610 / 2642 | 98% | 18.81 | 694 / 705 |
| pancreas | 99% | 596.68 | 326 / 328 | 98% | 20.47 | 174 / 178 |
| thymus | 100% | 891.15 | 653 / 653 | 96% | 14.87 | 580 / 605 |
| skin | 100% | 1778.66 | 1809 / 1809 | 96% | 29.78 | 451 / 472 |
| kidney | 100% | 738.65 | 89 / 89 | 88% | 13.81 | 796 / 901 |
| liver | 100% | 615.00 | 226 / 226 | 84% | 13.16 | 341 / 406 |
| adrenal gland | 100% | 1018.98 | 258 / 258 | 64% | 7.02 | 147 / 230 |
| adipose | 100% | 963.27 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 30.52 | 29 / 29 |
| spleen | 100% | 1155.66 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 47.48 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 18.71 | 1 / 1 |
| blood vessel | 100% | 768.36 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 625.73 | 799 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 531.75 | 838 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 66% | 8.60 | 53 / 80 |
| peripheral blood | 65% | 1218.11 | 601 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006913 | Biological process | nucleocytoplasmic transport |
| GO_0015031 | Biological process | protein transport |
| GO_0051664 | Biological process | nuclear pore localization |
| GO_0051292 | Biological process | nuclear pore complex assembly |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0006999 | Biological process | nuclear pore organization |
| GO_0051028 | Biological process | mRNA transport |
| GO_0007129 | Biological process | homologous chromosome pairing at meiosis |
| GO_0070762 | Cellular component | nuclear pore transmembrane ring |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0005643 | Cellular component | nuclear pore |
| GO_0031965 | Cellular component | nuclear membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005635 | Cellular component | nuclear envelope |
| GO_0016020 | Cellular component | membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0017056 | Molecular function | structural constituent of nuclear pore |
| GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
| Gene name | NDC1 |
| Protein name | Nucleoporin NDC1 (hNDC1) (Transmembrane protein 48) |
| Synonyms | TMEM48 |
| Description | FUNCTION: Component of the nuclear pore complex (NPC), which plays a key role in de novo assembly and insertion of NPC in the nuclear envelope. Required for NPC and nuclear envelope assembly, possibly by forming a link between the nuclear envelope membrane and soluble nucleoporins, thereby anchoring the NPC in the membrane. . |
| Accessions | Q9BTX1 ENST00000371429.4 [Q9BTX1-1] |
